Sanjeev Narula - 03 Feb 2025 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITCI	Restricted Stock Units	Award	$0	+22,727		$0.000000	22,727	03 Feb 2025	Common Stock	22,727		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock.
F2	On February 3, 2025, the reporting person was granted 22,727 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.